Japan’s foray into regenerative medicine takes on added importance for a nation wrestling with age, stagnation, and its place in the world. In a quiet operating room on Kyoto University’s medical ...

Japan’s health ministry has granted conditional, time-limited authorization for two stem-cell therapies derived from induced pluripotent stem (iPS) cells, endorsing them for use based on early safety ...

Dublin, March 31, 2026 (GLOBE NEWSWIRE)-- The "Japan Cell and Gene Therapy Manufacturing Market: Industry Trends and Future Forecast, Till 2035 - Distribution by Type of Therapy, Type of Scale, Type ...

Japan has granted conditional approval to a stem cell therapy that showed early success in improving movement in Parkinson’s patients, marking a milestone after decades of research setbacks. The ...

TOKYO (Reuters) - Japan's government and top carmakers, including Toyota Motor Corp, are joining forces to bet big that they can speed up the arrival of the fuel cell era: a still costly and complex ...

Japan’s Astellas Pharma and Yaskawa Electric Corporation inked an agreement to explore the development of an automated cell therapy production system. The two companies have worked together since 2017 ...

Japan has approved ground-breaking stem-cell treatments for Parkinson's and severe heart failure, one of the manufacturers and media reports said Friday, with the therapies expected to reach patients ...

Add Yahoo as a preferred source to see more of our stories on Google. Researchers from Nagoya University, led by Atsushi Noro, have introduced a groundbreaking phosphonic acid polymer electrolyte that ...

Authorities are closely monitoring additional announcements from Japan’s Ministry of Health, Labour and Welfare following the death of a Korean patient during stem cell treatment in Japan. Regulators ...

Stem cell therapies using induced pluripotent stem cells have received conditional approval in Japan for treating Parkinson’s disease and severe heart failure, advancing regenerative medicine into ...